Hematological blood parameters in residents of Yakutsk city recovered from coronavirus infection COVID-19
https://doi.org/10.25789/YMJ.2023.84.04
Abstract
The study is devoted to a comparative analysis of the results of the effect of COVID-19 coronavirus infection on hematological blood parameters in patients who have been ill after three, six, nine and twelve months. Monitoring of hematological parameters is important for the identification and control of patients who have undergone COVID-19, who need additional assistance, and stratification of the risk of severe course of the disease. The study involved 161 residents of Yakutsk aged 20 to 72 years who had suffered COVID-19 in different periods of the pandemic. The study of hematological parameters showed that the average indicators of the morphological composition of red and white blood in people who have had COVID-19 correspond to generally accepted standards, with the exception of the tendency to increase monocytes, basophils, ESR and a slight decrease in MCHC indicators, which indicates a recently transmitted infectious disease
About the Authors
L. I. Konstantinova
Yakut Science Center of Complex Medical Problems
Russian Federation
Russian Federation
Konstantinova Lena Ivanovna – PhD in Biology, researcher
E. D. Okhlopkova
Yakut Science Center of Complex Medical Problems
Russian Federation
Russian Federation
Okhlopkova Elena Dmitrievna – PhD, senior researcher
L. D. Olesova
Yakut Science Center of Complex Medical Problems
Russian Federation
Russian Federation
Olesova Lyubov Dygynovna – PhD, visiting scholar – head of the laboratory
A. I. Yakovleva
Yakut Science Center of Complex Medical Problems
Russian Federation
Russian Federation
Yakovleva Alexandra Ivanovna – PhD
L. V. Mironova
Yakut Science Center of Complex Medical Problems
Russian Federation
Russian Federation
Mironova Lyudmila Vasilyevna – Head of the Department, Clinical Diagnostic Laboratory of the YSC CMP Clinic
A. N. Romanova
Yakut Science Center of Complex Medical Problems
Russian Federation
Russian Federation
Romanova Anna Nikolaevna – MD, Director
References
1. Dynamics of platelet content in peripheral blood in different periods of the postcovid period / F.H. Nizamov [et al.] // Medical science and education of the Urals. 2023. Vol. 24. No. 3. P. 72-74.
2. Kozlov I.A., Tyurin I.N. Cardiovascular complications of COVID 19 // Bulletin of Anesthesiology and Resuscitation. 2020. Vol. 17 (4). P. 14-22. https://doi.org/10.21292/2078-5658-2020-17-4-14-22.
3. Prevention, diagnosis and treatment of new coronavirus infection (With OVID-19). Temporary methodological recommendations. Version 1 (29.01.20). Approved by the Ministry of Health of Russia.
4. The relationship of the indicators of the general blood test with the severity of the course of COVID-19 in hospitalized patients / N.S. Gubenko [et al.] // South-Russian Journal of Therapeutic Practice. 2021. 2 (1). P. 90-101.
5. Autoimmune haemolytic anaemia associated with COVID-19 infection / G. Lazarian [et al.] // Br J Haematol. 2020 Jul. 190 (1). P. 29-31. doi: 10.1111/bjh.16794.
6. Biomarkers associated with COVID-19 disease progression. G. Ponti [et al.] / Crit Rev Clin Lab Sci. 2020 Sep. 57 (6). P. 389-399. doi: 10.1080/10408363.2020.1770685.
7. Changes of hematological and immunological parameters in COVID-19 patients / X. Yuan [et al.] // Int J Hematol. 2020 Oct. 112 (4). P. 553- 559. doi: 10.1007/s12185-020-02930-w.
8. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis / A.J. Rodriguez-Morales [et al.] // Travel Med Infect Dis. 2020 Mar-Apr. 34:101623. doi: 10.1016/j.tmaid.2020.101623.
9. Gajendra S. Spectrum of hematological changes in COVID-19. Am J Blood Res. 2022 Feb 15. 12 (1). P. 43-53.
10. Hematological findings and complications of COVID-19 / E. Terpos [et al.] // Am J Hematol. 2020 Jul. 95 (7). P. 834-847. doi: 10.1002/ajh.25829.
11. Hematologic parameters in patients with COVID-19 infection / B.E. Fan [et al.] // Am J Hematol. 2020 Jun. 95 (6). P. E131-E134. doi: 10.1002/ajh.25774.
12. Lippi G, Mattiuzzi C. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematol Transfus Cell Ther. 2020 Apr-Jun. 42 (2). P. 116-117. doi: 10.1016/j.htct.2020.03.001.
13. Liu X, Zhang R, He G. Hematological findings in coronavirus disease 2019: indications of progression of disease. Ann Hematol. 2020 Jul. 99 (7). P. 1421-1428. doi: 10.1007/s00277-020-04103-5.
14. Post-acute COVID 19 syndrome / Nalbandian A. [et al.] // Nat. Med. 2021. 27. P. 601-615. https://doi.org/10.1038/s41591-021-01283-z.
15. Sharing research data and findings relevant to the novel coronavirus (COVID-19) outbreak [Internet]. Wellcome; 2020 Jan 31. URL: https://wellcome.org/coronavirus-covid-19/open-data.
16. The role of red blood cell distribution width in cardiovascular and thrombotic disorders. Clinical chemistry and laboratory medicine / M. Montagnana [et al.] // 2011. 50(4). P. 635– 641. DOI: 10.1515/cclm.2011.831.
17. Validation of Predictors of Disease Severity and Outcomes in COVID-19 Patients: A Descriptive and Retrospective Study / L. Tan [et al.] // Med. 2020. 1(1). P. 128–138. DOI: 10.1016/j.medj.2020.05.002.
18.
Review
For citations:
Konstantinova L.I., Okhlopkova E.D., Olesova L.D., Yakovleva A.I., Mironova L.V., Romanova A.N. Hematological blood parameters in residents of Yakutsk city recovered from coronavirus infection COVID-19. Yakut Medical Journal. 2023;(4):16-20. https://doi.org/10.25789/YMJ.2023.84.04
Views:
20
Email this article 